Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Hydroxyurea Treatment for Sickle Cell Disease
source: St. Jude Children’s Research Hospital
year: N/A
summary/abstract:Hydroxyurea is a medicine that can help children and adults with sickle cell disease.
Research studies show that hydroxyurea lowers the following:
• The numbers of acute chest syndrome (pneumonia) events
• The number of pain crises
• The need for blood transfusions
• The number of trips to the hospital
Hydroxyurea also might prevent damage to the spleen, kidneys, lungs, and brain.
Hydroxyurea is given by mouth one (1) time each day. It comes in liquid or capsule form. The U.S. Food and Drug Administration (FDA) has approved it for the treatment of adults with severe sickle cell disease. St. Jude Children’s Research Hospital and other medical centers have carried out research studies that demonstrated the safety of hydroxyurea therapy for young children and infants with sickle cell disease.
read more
+myBinderRelated Content
-
Alzheimer’s Treatment Memantine Shows Promise in Treating Sickle Cell DiseaseMemantine, a standard treatment for Alzh...
-
Bioverativ and Sangamo announce FDA acceptance of IND application for gene-edited cell therapy BIVV003 to treat sick...Bioverativ Inc., a Sanofi company dedi...
-
Debbie’s Story on BBC2 Hospitalhttps://www.facebook.com/bbctwo/videos/1...
-
Hyperhemolysis syndrome in patients with sickle cell anemia: report of three casesBACKGROUND: Sickle cell anemia (SCA) is ...
-
Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic sy...The risk and clinical significance of ca...
-
NIH Launches new Collaboration to Develop Gene-Based Cures for Sickle Cell Disease and HIV on Global ScaleThe National Institutes of Health plans ...
-
La Jolla Pharmaceutical company announces initiation of pivotal clinical study of LJPC-401 in patients with beta tha...La Jolla Pharmaceutical company today an...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
SomeBodyToTalkTo connects people affected by rare diseases with trusted resources, supportive communities, and opportunities to share their experiences.